Nationwide Lab history

Our sister laboratory, Cambridge Specialist Laboratory Services was formed in 1998 by a small group of scientists and technicians with many years of experience in veterinary diagnostics and radioimmunoassay.

2001 ViroMed acquisition ViroMed, one of the leading laboratories in molecular microbial testing using real-time PCR platforms, becomes a part of LabCorp.

2002 LabCorp acquires Dynacare With the acquisition of Dynacare, LabCorp expands its geographic presence in the western and midwestern United States, as well as creating LabCorp’s first significant international presence in Canada.

On 1st April 2003 North Western Laboratories Ltd changed its trading name to Nationwide Laboratories.

2005 LabCorp acquires Esoterix, Inc. and US LABS Both Esoterix, Inc. and US LABS become part of the LabCorp family.

2006 Litholink becomes part of LabCorp LabCorp acquires Litholink, a leading provider of testing that provides targeted treatment information, helping physicians better manage and prevent chronic diseases, including kidney stones and chronic kidney disease.

2008 Tandem Laboratories purchased by LabCorp LabCorp expands its clinical trials, personalized medicine, and companion diagnostic capabilities by purchasing Tandem Laboratories.

2009 Monogram Biosciences is purchased by LabCorp LabCorp purchases Monogram Biosciences, a recognized leader in the discovery and commercialization of products to guide and improve the treatment of HIV, cancer, and other serious diseases.

2010 LabCorp finalizes acquisition of Genzyme Genetics LabCorp completes its $1 billion acquisition of Genzyme Genetics, a business unit of Genzyme Corporation.

MD Labs was founded in 2011.

2012 LabCorp acquires MEDTOX, forms three new subsidiaries 2012 is a big year for the LabCorp brand.

On 15th August 2013 NVSL was acquired by Paterson Companies Inc and became part of the Veterinary Division of Patterson.

2015 Acquisition of Covance headlines a banner year In February 2015, LabCorp completes its $6 billion purchase of Covance, Inc., creating the world’s leading health care diagnostics company.

2017 LabCorp acquires Chiltern, PAML and Mount Sinai’s Clinical Outreach Laboratories Chiltern becomes part of the company’s Covance Drug Development business.